Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Arexvy and Abrysvo are approved to prevent RSV-associated lower respiratory tract disease in adults aged 50 to 59 and 18 to ...

"It's amazing to me," the 6ft 6in (1.98m) 19-year-old Olympic silver medalist said. "I'm so happy to represent France, but not only France, Cameroon and Congo. I'm a multicultural person. I will work ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Both AstraZeneca and GSK rely on the US for a large portion of ... while Swiss firm Roche fell 5.8 per cent, and France’s Sanofi slipped 6.9 per cent. The rout also caught the US pharma sector ...

Rafale-M operations, anti-submarine warfare in focus during Indo-France naval exercise The CCS approval for the government-to-government deal is the final step, and the agreement now awaits formal ...

GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...

French President Emmanuel Macron said on Wednesday that France could recognise a Palestinian state at an upcoming UN conference, adding that in turn some countries in the Middle East could ...

In a major shift, Emmanuel Macron said France will move to formally recognize the state of Palestine in the coming months. The French president said in a TV interview Wednesday that recognition of ...

GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access These grants are part of GSK’s COiMMUNITY ...